African Neuroscience on the Global Stage: Nigeria as a Model

Mahmoud Bukar Maina, Yunusa Mohammed Garba, Ali Bukar Maina, Ahmad Umar, Salihu Abubakar Tijjani, Ibrahim Harun Arrashid, Muhammad Abdurrazak, Hamidu Suleiman Kwairanga, Aisha Umar Yaro, Mosab Ali Awadelkareem, Tom Baden2018 · DOI

TL;DR

This paper analyzes Nigerian neuroscience publications from 1996-2017 to understand the continent's scientific output. It reveals a reliance on basic techniques and non-genetically modified model organisms, with limited translation of findings into clinical applications, highlighting key areas for investment in training and infrastructure to boost global impact.

What Problem Does This Paper Address?

Africa's contribution to global scientific knowledge production, particularly in neuroscience, lags behind other regions. This gap is attributed to various challenges, including limited infrastructure, funding, and access to advanced research tools. To address this, the authors aim to establish a framework for evaluating neuroscience output from African laboratories, using Nigeria as a model. By understanding the strengths and weaknesses of Nigerian neuroscience research, they seek to inform strategies for developing more robust programs that cater to specific needs and ultimately enhance the continent's global scientific standing.

Methods

The study employed a multi-stage approach to analyze Nigerian neuroscience publications. Initially, a PubMed search was conducted using specific keywords to retrieve relevant articles. These were then filtered using defined exclusion and inclusion criteria to specifically identify research originating from Nigerian laboratories. To categorize the research into "basic" or "clinical and epidemiological" studies, a machine learning approach was utilized. This involved manually annotating a subset of articles and then training a support vector machine (SVM) and a decision tree algorithm to classify the remaining publications. Beyond categorization, the study extracted data on model species used, research techniques employed, citation metrics, and journal impact factors.

Datasets

The primary dataset for this study comprised neuroscience publications indexed in PubMed between 1996 and 2017, originating from Nigerian laboratories. A total of 572 articles were selected after rigorous filtering. For the machine learning classification task, 10% of these articles (57 randomly chosen) were manually annotated to serve as training data for the SVM and decision tree algorithms. The paper does not introduce new benchmark datasets.

Key Insights and Ideas

  • Underutilization of Genetically Amenable Models: A striking finding is the complete absence of popular, cost-effective model organisms like Drosophila and zebrafish in Nigerian neuroscience research. This is a missed opportunity, especially given their advantages in research and potential relevance to African contexts.
  • Technological Gap: The research highlights a significant disparity in the adoption of advanced neuroscience techniques, with a strong reliance on "standard" methods like histology and basic behavioral analysis, while modern techniques like PCR, Western blotting, and advanced microscopy are rarely employed.
  • Disconnect Between Basic and Clinical Research: Despite a substantial portion of basic research investigating medicinal plants, there's a notable lack of translation into clinical applications within Nigeria, suggesting a disconnect between discovery and patient care.
  • Journal Visibility: Most Nigerian neuroscience research is published in lower-impact African journals, which often lack international indexing, thus limiting global visibility and impact.

Key Results

  • Out of 1,247 initially retrieved articles, 572 were identified as originating from Nigerian laboratories.
  • Of these 572 articles, 55.5% were categorized as clinical and epidemiological studies, and 44.5% as basic neuroscience.
  • Only one Nigerian-led neuroscience paper was published in a "top-tier" international journal (impact factor >8) over the 21-year period.
  • Approximately 55% of articles were published in journals with an impact factor between 1-4.
  • Basic research studies were generally more cited and published in higher impact factor journals compared to clinical studies.
  • No studies utilized genetically amenable model systems like zebrafish or Drosophila; instead, human (54%), rat (30%), and wild-type mice (11%) were the primary models.
  • Only 8% of basic neuroscience studies employed advanced techniques.
  • 41% of basic neuroscience studies investigated medicinal plants, but none led to local clinical research.

Limitations and Future Work

The authors acknowledge the variability in search engine results when assessing the "true" number of Nigerian-led publications, highlighting the importance of their specific filtering criteria. They also note that impact factor and citation counts are imperfect metrics for research quality.

Future work should focus on:

  • Investment in Training and Infrastructure: Prioritizing sustained training in modern research techniques and upgrading laboratory infrastructure is crucial.
  • Promotion of Genetically Amenable Model Species: Encouraging the adoption of affordable and tractable model organisms like Drosophila could significantly advance research.
  • Bridging Basic and Clinical Research: Fostering collaboration between basic and clinical scientists is essential to translate research findings into tangible patient care solutions.
  • Expanding the Scope: The authors suggest that in time, it will be important to assess neuroscience output across the entire African continent to gain a broader perspective.

Summary updated

Abstract

Several challenges contribute to Africa’s trailing position in the global production of knowledge. Decades of focused work through international and local programmes have thus far been unable to lift the continent onto its scientific feet. To learn more about the strengths and weaknesses of neuroscience research carried out on the continent today, that would enable the development of robust programmes focusing on specific needs, a strategy is required to extract information about specific contributions of African laboratories. Nigeria, Africa’s most populous nation, is among the top beneficiaries of international programmes promoting neuroscience research in Africa. Therefore, to establish and test a framework for evaluating neuroscience output from the continent, we here focussed on Nigeria’s neuroscience publications over the past two decades. Using PubMed key-word search and defined exclusion criteria, we extracted 572 neuroscience articles from Nigeria-based laboratories published between 1996 and 2017. Articles were automatically categorised into clinical and epidemiological studies (55.5%) or basic neuroscience (44.5%) using a support vector machine and decision tree algorithm. From here, we extracted each publication’s use of model species, methods, citations received and the publishing journal’s metrics.We find that over the 21 year period surveyed, only one Nigerian-led neuroscience paper was published in a “top-tier” international journal with an impact factor of >8. However, about half (55%) of PubMed indexed articles were published in reputable journals with an impact factor between 1-4. These publications primarily comprised basic (61%), rather than clinical and epidemiological studies (39%) which were instead mostly published in lower-ranking journals. Next, we find a worrying account of model species and research tools employed in Nigerian-based neuroscience. For example, no studies used genetically amenable model systems such as zebrafish, Drosophila, C.elegans, or transgenic mouse strains. Instead, popular model species were human (54%), rat (30%) and wild-type mice (11%). In line, research techniques employed were dominated by “basic” techniques such as Hematoxylin and Eosin stainings or classical behavioural analysis, with only 8% of studies using more modern techniques like PCR, Western blotting or forms of fluorescence microscopy. Perhaps as one consequence, even though medicinal plants have been used to treat diseases for decades by locals, and 41% of basic neuroscience studies investigated their potential utility in treating disease, none made it into local clinical research.Together, these findings highlight two clear access points for the support of Nigerian neuroscience in the future: Investment in the training and infrastructure in the use of more modern research techniques, and the widespread promotion of genetically amenable model species. Moreover, any such effort might consider specifically targeting existing basic over clinical or epidemiological research efforts. In time, it will be important to also assess the neuroscience output across the entire continent.
BibTeX
@misc{maina2018african,
  author = {Mahmoud Bukar Maina and Yunusa Mohammed Garba and Ali Bukar Maina and Ahmad Umar and Salihu Abubakar Tijjani and Ibrahim Harun Arrashid and Muhammad Abdurrazak and Hamidu Suleiman Kwairanga and Aisha Umar Yaro and Mosab Ali Awadelkareem and Tom Baden},
  title = {{African Neuroscience on the Global Stage: Nigeria as a Model}},
  year = {2018},
  doi = {10.31730/osf.io/ahv2t},
}
Figure